Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet: association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4alpha expression

Drug Metab Dispos. 2006 Oct;34(10):1677-87. doi: 10.1124/dmd.106.010645. Epub 2006 Jun 30.

Abstract

Inulin enzymatically synthesized from sucrose is a dietary component that completely escapes glucide digestion. Supplementing inulin to a high-fat and high-sucrose diet (HF) ameliorated hypertriglycemia and hepatic steatosis in 8-week-fed rats by suppressing elevated levels of serum triacylglycerols, fatty acids, and glucose, and the accumulation of hepatic triacylglycerols and fatty acids. Inulin intake prevented phenobarbital (PB)- and dexamethasone-induced liver injuries in the HF group. No significant alteration in the baseline expression of CYP2B, CYP2C11, CYP3A, and NADPH-cytochrome P450 (P450) reductase mRNAs and proteins was found. In contrast, baseline and PB-treated expressions of CYP2E1 mRNA were reduced in HF-fed rats. The induction of P450s in response to PB was affected by the nutritional status of the rats; mRNA levels of CYP2B1 and CYP3A1 after PB treatment, as assessed by quantitative real-time polymerase chain reaction analysis were reduced in the inulin-supplemented HF (HF+I) group, compared with those in the HF group. Western blot analysis detected the corresponding changes of CYP2B and CYP3A proteins. These alterations were correlated with changes in hepatic thiobarbituric acid-reactive substances. Furthermore, no significant difference in the expression of nuclear receptors constitutive androstane receptor, pregnane X receptor, and retinoid X receptor alpha and coactivator peroxisome proliferator-activated receptor-gamma coactivator 1alpha proteins was found in the hepatic nucleus between the HF and HF+I groups, but the expression of hepatocyte nuclear factor alpha (HNF4alpha) protein was significantly reduced in the HF+I group. Taken together, these results indicate that inulin intake ameliorates PB-induced liver injury, associated with a decline in lipid accumulation and PB-induced expression of CYP2B and CYP3A, which may be related by a reduction in the nuclear expression of HNF4alpha.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alanine Transaminase / blood
  • Animals
  • Aspartate Aminotransferases / blood
  • Constitutive Androstane Receptor
  • Cytochrome P-450 Enzyme System / genetics*
  • Cytochrome P-450 Enzyme System / metabolism
  • Dexamethasone / administration & dosage
  • Dexamethasone / toxicity
  • Dietary Fats / administration & dosage
  • Dietary Fats / toxicity
  • Dietary Sucrose / administration & dosage
  • Dietary Sucrose / toxicity
  • Fatty Liver / blood
  • Fatty Liver / chemically induced
  • Fatty Liver / drug therapy*
  • Gene Expression / drug effects
  • Hepatocyte Nuclear Factor 4 / genetics*
  • Hepatocyte Nuclear Factor 4 / metabolism
  • Hepatocytes / cytology
  • Hepatocytes / drug effects
  • Hepatocytes / metabolism
  • Immunoblotting
  • Inulin / administration & dosage
  • Inulin / pharmacology
  • Inulin / therapeutic use*
  • Male
  • PPAR alpha / metabolism
  • Phenobarbital / administration & dosage
  • Phenobarbital / toxicity
  • Pregnane X Receptor
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Wistar
  • Receptors, Cytoplasmic and Nuclear / metabolism
  • Receptors, Steroid / metabolism
  • Retinoid X Receptors / metabolism
  • Time Factors
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Xenobiotics / administration & dosage
  • Xenobiotics / toxicity*

Substances

  • Constitutive Androstane Receptor
  • Dietary Fats
  • Dietary Sucrose
  • Hepatocyte Nuclear Factor 4
  • PPAR alpha
  • Pregnane X Receptor
  • RNA, Messenger
  • Receptors, Cytoplasmic and Nuclear
  • Receptors, Steroid
  • Retinoid X Receptors
  • Transcription Factors
  • Xenobiotics
  • Dexamethasone
  • Inulin
  • Cytochrome P-450 Enzyme System
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Phenobarbital